Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia
This study has been completed.
Sponsor:
Karolinska University Hospital
Collaborator:
Schering Nordiska AB
Information provided by:
Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT00162851
First received: September 8, 2005
Last updated: July 23, 2007
Last verified: August 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2006 |
| Estimated Primary Completion Date: | No date given |